Skip to main content
. 2022 Jan 18;13(2):2927–2942. doi: 10.1080/21655979.2021.2017698

Figure 4.

Figure 4.

miR-665-3p agomir aggravates HFD-induced hepatic oxidative stress and inflammation. (a) Hepatic ROS levels determined by DCFH-DA probe. (b) H2O2 levels in the liver. (c) MDA levels in the liver. (d-e) Hepatic IL-1β, IL-6, MCP-1, TNF-α and IL-10 levels determined by the commercial ELISA kits. All results were expressed as the means ± standard deviations, n = 6 for each group, and *P < 0.05 was considered statistically significant.